$GENE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSCIENT PHARMACEUTICALS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSCIENT PHARMACEUTICALS CORP. Get notifications about new insider transactions in OSCIENT PHARMACEUTICALS CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 29 2009 | GENE | OSCIENT PHARMACEUT ... | BB BIOVENTURES L P | 10% Owner | Buy | C | 1.10 | 4,222 | 4,644 | 4,222 | 0 to 4.2 K |
May 26 2009 | GENE | OSCIENT PHARMACEUT ... | GLG Partners LP | 10% Owner | Sell | S | 0.30 | 785,616 | 236,942 | 73,923 | 859.5 K to 73.9 K (-91.40 %) |
May 15 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.21 | 468,230 | 98,141 | 0 | 468.2 K to 0 (-100.00 %) |
May 15 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.23 | 108,162 | 24,921 | 468,230 | 576.4 K to 468.2 K (-18.77 %) |
May 15 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.25 | 416,391 | 104,473 | 576,392 | 992.8 K to 576.4 K (-41.94 %) |
May 13 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Buy | C | 0.00 | 992,783 | 0 | 992,783 | 0 to 992.8 K |
May 12 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.27 | 100,325 | 27,409 | 0 | 100.3 K to 0 (-100.00 %) |
Apr 01 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.13 | 70,000 | 8,897 | 100,325 | 170.3 K to 100.3 K (-41.10 %) |
Apr 01 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.13 | 150,000 | 19,065 | 170,325 | 320.3 K to 170.3 K (-46.83 %) |
Mar 27 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.13 | 200,000 | 26,040 | 320,325 | 520.3 K to 320.3 K (-38.44 %) |
Mar 27 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.13 | 160,269 | 20,162 | 520,325 | 680.6 K to 520.3 K (-23.55 %) |
Mar 27 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.18 | 967,939 | 178,682 | 680,594 | 1.6 M to 680.6 K (-58.72 %) |
Jul 30 2008 | GENE | OSCIENT PHARMACEUT ... | Glickman Mark A | SVP, Sales & Market ... | Option Exercise | A | 1.48 | 15,000 | 22,125 | 15,000 | |
Jul 30 2008 | GENE | OSCIENT PHARMACEUT ... | Glickman Mark A | SVP, Sales & Market ... | Grant | A | 0.00 | 10,000 | 0 | 36,157 | 26.2 K to 36.2 K (+38.23 %) |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 | |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 300 | 0 | 1,200 | 900 to 1.2 K (+33.33 %) |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 | |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Grant | A | 0.00 | 300 | 0 | 6,958 | 6.7 K to 7 K (+4.51 %) |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | Leone John R | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 | |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | Leone John R | Director | Grant | A | 0.00 | 300 | 0 | 900 | 600 to 900 (+50.00 %) |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | Mattson William R Jr | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 | |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | Mattson William R Jr | Director | Grant | A | 0.00 | 300 | 0 | 1,200 | 900 to 1.2 K (+33.33 %) |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 | |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Grant | A | 0.00 | 300 | 0 | 14,141 | 13.8 K to 14.1 K (+2.17 %) |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 | |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 300 | 0 | 2,553 | 2.3 K to 2.6 K (+13.32 %) |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 | |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 300 | 0 | 1,340 | 1 K to 1.3 K (+28.85 %) |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 | |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Grant | A | 0.00 | 300 | 0 | 4,850 | 4.6 K to 4.9 K (+6.59 %) |
Mar 13 2008 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Option Exercise | A | 2.16 | 35,000 | 75,600 | 35,000 | |
Mar 13 2008 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Grant | A | 0.00 | 14,000 | 0 | 43,825 | 29.8 K to 43.8 K (+46.94 %) |
Mar 13 2008 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Option Exercise | A | 2.16 | 36,629 | 79,119 | 36,629 | |
Mar 13 2008 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Grant | A | 0.00 | 14,672 | 0 | 46,469 | 31.8 K to 46.5 K (+46.14 %) |
Mar 13 2008 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Option Exercise | A | 2.16 | 45,303 | 97,854 | 45,303 | |
Mar 13 2008 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Grant | A | 0.00 | 18,147 | 0 | 67,210 | 49.1 K to 67.2 K (+36.99 %) |
Feb 12 2008 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Buy | P | 1.22 | 500 | 610 | 29,825 | 29.3 K to 29.8 K (+1.71 %) |
Feb 12 2008 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Buy | P | 1.24 | 2,000 | 2,479 | 31,797 | 29.8 K to 31.8 K (+6.71 %) |
Jan 04 2008 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Buy | J | 1.28 | 2,735 | 3,508 | 29,325 | 26.6 K to 29.3 K (+10.29 %) |
Dec 10 2007 | GENE | OSCIENT PHARMACEUT ... | Leone John R | Director | Option Exercise | A | 1.47 | 1,500 | 2,205 | 1,500 | |
Dec 10 2007 | GENE | OSCIENT PHARMACEUT ... | Leone John R | Director | Grant | A | 0.00 | 600 | 0 | 600 | 0 to 600 |
Sep 14 2007 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Buy | P | 2.75 | 2,672 | 7,348 | 49,063 | 46.4 K to 49.1 K (+5.76 %) |
Sep 14 2007 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Buy | P | 2.75 | 478 | 1,315 | 46,391 | 45.9 K to 46.4 K (+1.04 %) |
Sep 14 2007 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Buy | P | 2.70 | 1,318 | 3,559 | 45,913 | 44.6 K to 45.9 K (+2.96 %) |
Sep 14 2007 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Buy | P | 2.69 | 5,432 | 14,612 | 44,595 | 39.2 K to 44.6 K (+13.87 %) |
Sep 14 2007 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Buy | P | 2.68 | 100 | 268 | 39,163 | 39.1 K to 39.2 K (+0.26 %) |
Sep 17 2007 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Buy | P | 2.65 | 4,525 | 11,970 | 26,590 | 22.1 K to 26.6 K (+20.51 %) |
Sep 17 2007 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Buy | P | 2.73 | 2,975 | 8,127 | 22,065 | 19.1 K to 22.1 K (+15.58 %) |
Sep 13 2007 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Buy | P | 2.77 | 2,700 | 7,479 | 4,550 | 1.9 K to 4.6 K (+145.95 %) |
Jul 06 2007 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Buy | J | 3.88 | 802 | 3,115 | 19,090 | 18.3 K to 19.1 K (+4.39 %) |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | Voris John E | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | Voris John E | Director | Grant | A | 0.00 | 300 | 0 | 600 | 300 to 600 (+100.00 %) |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 300 | 0 | 2,253 | 2 K to 2.3 K (+15.36 %) |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | Mattson William R Jr | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | Mattson William R Jr | Director | Grant | A | 0.00 | 300 | 0 | 900 | 600 to 900 (+50.00 %) |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Grant | A | 0.00 | 300 | 0 | 1,850 | 1.6 K to 1.9 K (+19.35 %) |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | FLAMENBAUM WALTER MD | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | FLAMENBAUM WALTER MD | Director | Grant | A | 0.00 | 300 | 0 | 900 | 600 to 900 (+50.00 %) |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 300 | 0 | 900 | 600 to 900 (+50.00 %) |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Grant | A | 0.00 | 300 | 0 | 13,841 | 13.5 K to 13.8 K (+2.22 %) |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Grant | A | 0.00 | 300 | 0 | 6,658 | 6.4 K to 6.7 K (+4.72 %) |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 4.91 | 750 | 3,683 | 750 | |
Jun 08 2007 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 300 | 0 | 1,040 | 740 to 1 K (+40.54 %) |
Mar 09 2007 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Option Exercise | A | 4.94 | 19,278 | 95,233 | 19,278 | |
Mar 09 2007 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Grant | A | 0.00 | 7,722 | 0 | 18,288 | 10.6 K to 18.3 K (+73.08 %) |
Mar 09 2007 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Option Exercise | A | 4.94 | 48,838 | 241,260 | 48,838 | |
Mar 09 2007 | GENE | OSCIENT PHARMACEUT ... | Colangelo Dominick | EVP Corporate Dev & ... | Grant | A | 0.00 | 19,562 | 0 | 29,797 | 10.2 K to 29.8 K (+191.13 %) |
Mar 09 2007 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Option Exercise | A | 4.94 | 60,404 | 298,396 | 60,404 | |
Mar 09 2007 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Grant | A | 0.00 | 24,196 | 0 | 39,063 | 14.9 K to 39.1 K (+162.75 %) |
Jan 05 2007 | GENE | OSCIENT PHARMACEUT ... | Maitre Philippe M | SVP & CFO | Buy | J | 4.30 | 1,816 | 7,811 | 10,566 | 8.8 K to 10.6 K (+20.75 %) |
Dec 29 2006 | GENE | OSCIENT PHARMACEUT ... | RAUSCHER STEVEN M | CEO and President | Sell | J | 5.06 | 3,000 | 15,180 | 14,867 | 17.9 K to 14.9 K (-16.79 %) |
Dec 08 2006 | GENE | OSCIENT PHARMACEUT ... | FLAMENBAUM WALTER MD | Director | Option Exercise | A | 6.01 | 1,500 | 9,008 | 1,500 | |
Dec 08 2006 | GENE | OSCIENT PHARMACEUT ... | FLAMENBAUM WALTER MD | Director | Grant | A | 0.00 | 600 | 0 | 600 | 0 to 600 |
Aug 22 2006 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Option Exercise | A | 1.24 | 12,000 | 14,880 | 12,000 | |
Aug 22 2006 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 4,800 | 0 | 4,800 | 0 to 4.8 K |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | Voris John E | Director | Option Exercise | A | 1.19 | 6,000 | 7,140 | 6,000 | |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | Voris John E | Director | Grant | A | 0.00 | 2,400 | 0 | 2,400 | 0 to 2.4 K |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Option Exercise | A | 1.19 | 6,000 | 7,140 | 6,000 | |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 2,400 | 0 | 5,919 | 3.5 K to 5.9 K (+68.20 %) |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.19 | 6,000 | 7,140 | 6,000 | |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 2,400 | 0 | 15,619 | 13.2 K to 15.6 K (+18.16 %) |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Option Exercise | A | 1.19 | 6,000 | 7,140 | 6,000 | |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Grant | A | 0.00 | 2,400 | 0 | 108,326 | 105.9 K to 108.3 K (+2.27 %) |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | KIRBY PAMELA J | Director | Option Exercise | A | 1.19 | 6,000 | 7,140 | 6,000 | |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | KIRBY PAMELA J | Director | Grant | A | 0.00 | 2,400 | 0 | 2,400 | 0 to 2.4 K |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Option Exercise | A | 1.19 | 6,000 | 7,140 | 6,000 | |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | HENNESSEY ROBERT J | Director | Grant | A | 0.00 | 2,400 | 0 | 50,860 | 48.5 K to 50.9 K (+4.95 %) |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | Mattson William R Jr | Director | Option Exercise | A | 1.19 | 12,000 | 14,280 | 12,000 | |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | Mattson William R Jr | Director | Grant | A | 0.00 | 4,800 | 0 | 4,800 | 0 to 4.8 K |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Option Exercise | A | 1.19 | 6,000 | 7,140 | 6,000 | |
Jun 12 2006 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Grant | A | 0.00 | 2,400 | 0 | 12,400 | 10 K to 12.4 K (+24.00 %) |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 12,083 | 846 | 372,028 | |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 24,013 | 1,681 | 384,111 | |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.20 | 8,096 | 9,715 | 164,633 | 172.7 K to 164.6 K (-4.69 %) |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.25 | 3,987 | 4,984 | 172,729 | 176.7 K to 172.7 K (-2.26 %) |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 12,083 | 846 | 176,716 | 164.6 K to 176.7 K (+7.34 %) |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.20 | 1,323 | 1,588 | 164,633 | 166 K to 164.6 K (-0.80 %) |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.21 | 6,013 | 7,276 | 165,956 | 172 K to 166 K (-3.50 %) |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.22 | 14,677 | 17,906 | 171,969 | 186.6 K to 172 K (-7.86 %) |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.24 | 2,000 | 2,480 | 186,646 | 188.6 K to 186.6 K (-1.06 %) |
Jun 09 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 24,013 | 1,681 | 188,646 | 164.6 K to 188.6 K (+14.59 %) |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 39,798 | 2,786 | 408,124 | |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 5,217 | 365 | 447,922 | |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.24 | 22,424 | 27,806 | 164,633 | 187.1 K to 164.6 K (-11.99 %) |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.25 | 9,934 | 12,418 | 187,057 | 197 K to 187.1 K (-5.04 %) |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.26 | 5,440 | 6,854 | 196,991 | 202.4 K to 197 K (-2.69 %) |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.27 | 2,000 | 2,540 | 202,431 | 204.4 K to 202.4 K (-0.98 %) |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 39,798 | 2,786 | 204,431 | 164.6 K to 204.4 K (+24.17 %) |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.25 | 4,967 | 6,209 | 164,633 | 169.6 K to 164.6 K (-2.93 %) |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.30 | 250 | 325 | 169,600 | 169.9 K to 169.6 K (-0.15 %) |
Jun 05 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 5,217 | 365 | 169,850 | 164.6 K to 169.9 K (+3.17 %) |
Jun 02 2006 | GENE | OSCIENT PHARMACEUT ... | PATOU GARY | Director | Sell | S | 1.26 | 20,000 | 25,200 | 105,926 | 125.9 K to 105.9 K (-15.88 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 5,200 | 364 | 453,139 | |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 4,785 | 335 | 458,339 | |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 34,042 | 2,383 | 463,124 | |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.30 | 5,200 | 6,760 | 164,633 | 169.8 K to 164.6 K (-3.06 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 5,200 | 364 | 169,833 | 164.6 K to 169.8 K (+3.16 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.30 | 2,985 | 3,881 | 164,633 | 167.6 K to 164.6 K (-1.78 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.31 | 1,800 | 2,358 | 167,618 | 169.4 K to 167.6 K (-1.06 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 4,785 | 335 | 169,418 | 164.6 K to 169.4 K (+2.91 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.30 | 10,597 | 13,776 | 164,633 | 175.2 K to 164.6 K (-6.05 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.31 | 17,745 | 23,246 | 175,230 | 193 K to 175.2 K (-9.20 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.32 | 5,600 | 7,392 | 192,975 | 198.6 K to 193 K (-2.82 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.34 | 100 | 134 | 198,575 | 198.7 K to 198.6 K (-0.05 %) |
May 31 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 34,042 | 2,383 | 198,675 | 164.6 K to 198.7 K (+20.68 %) |
May 26 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 73,958 | 5,177 | 497,166 | |
May 26 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.30 | 15,000 | 19,500 | 164,633 | 179.6 K to 164.6 K (-8.35 %) |
May 26 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.31 | 11,000 | 14,410 | 179,633 | 190.6 K to 179.6 K (-5.77 %) |
May 26 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.32 | 9,933 | 13,112 | 190,633 | 200.6 K to 190.6 K (-4.95 %) |
May 26 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.33 | 13,474 | 17,920 | 200,566 | 214 K to 200.6 K (-6.30 %) |
May 26 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.34 | 19,087 | 25,577 | 214,040 | 233.1 K to 214 K (-8.19 %) |
May 26 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.35 | 5,464 | 7,376 | 233,127 | 238.6 K to 233.1 K (-2.29 %) |
May 26 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 73,958 | 5,177 | 238,591 | 164.6 K to 238.6 K (+44.92 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Buy | P | 1.34 | 5,000 | 6,700 | 10,000 | 5 K to 10 K (+100.00 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Buy | P | 1.32 | 25 | 33 | 5,000 | 5 K to 5 K (+0.50 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | STONE DAVID K | Director | Buy | P | 1.33 | 4,975 | 6,617 | 4,975 | 0 to 5 K |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 25,463 | 1,782 | 571,124 | |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Option Exercise | M | 0.07 | 36,537 | 2,558 | 596,587 | |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.35 | 3,000 | 4,050 | 202,334 | 205.3 K to 202.3 K (-1.46 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.36 | 3,000 | 4,080 | 205,334 | 208.3 K to 205.3 K (-1.44 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.37 | 6,000 | 8,220 | 208,334 | 214.3 K to 208.3 K (-2.80 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.38 | 3,463 | 4,779 | 214,334 | 217.8 K to 214.3 K (-1.59 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.39 | 10,000 | 13,900 | 217,797 | 227.8 K to 217.8 K (-4.39 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Buy | M | 0.07 | 25,463 | 1,782 | 227,797 | 202.3 K to 227.8 K (+12.58 %) |
May 24 2006 | GENE | OSCIENT PHARMACEUT ... | SINGER DAVID B | Director | Sell | S | 1.34 | 980 | 1,313 | 202,334 | 203.3 K to 202.3 K (-0.48 %) |